Tg Therapeutics (TGTX) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Tg Therapeutics (TGTX) over the last 10 years, with Q3 2025 value amounting to -$1.1 billion.
- Tg Therapeutics' Retained Earnings rose 3093.42% to -$1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year increase of 3093.42%. This contributed to the annual value of -$1.5 billion for FY2024, which is 150.61% up from last year.
- As of Q3 2025, Tg Therapeutics' Retained Earnings stood at -$1.1 billion, which was up 3093.42% from -$1.5 billion recorded in Q2 2025.
- Tg Therapeutics' 5-year Retained Earnings high stood at -$1.1 billion for Q1 2021, and its period low was -$1.6 billion during Q2 2023.
- In the last 5 years, Tg Therapeutics' Retained Earnings had a median value of -$1.5 billion in 2022 and averaged -$1.4 billion.
- Per our database at Business Quant, Tg Therapeutics' Retained Earnings tumbled by 4621.2% in 2021 and then soared by 3093.42% in 2025.
- Quarter analysis of 5 years shows Tg Therapeutics' Retained Earnings stood at -$1.3 billion in 2021, then dropped by 14.93% to -$1.5 billion in 2022, then decreased by 1.67% to -$1.6 billion in 2023, then increased by 1.51% to -$1.5 billion in 2024, then increased by 27.74% to -$1.1 billion in 2025.
- Its Retained Earnings was -$1.1 billion in Q3 2025, compared to -$1.5 billion in Q2 2025 and -$1.5 billion in Q1 2025.